跳至主要内容
临床试验/NCT04823364
NCT04823364终止不适用

Measuring Glutamate and GABA Brain Levels in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Using Magnetic Resonance Spectroscopy (MRS)

Weizmann Institute of Science3 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年7月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
60
试验地点
3
主要终点
Glu and GABA levels measured by MRS in ACC brain area

研究概览

简要总结

Background:

Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent neurobiological brain disorders. Diagnosis of ADHD in adults is complex and subjective. Recent studies give further support for the involvement of glutamatergic and GABAergic neurotransmitters in the pathophysiology of ADHD. Studies show that glutamate (Glu) and GABA change according to stimulant treatment. Measuring modulations in the anterior cingulate cortex (ACC) of Glu and GABA may help to explore the pathophysiology of ADHD and give a diagnostic biomarker tool for ADHD in adults.

Aim:

To characterize Glu and GABA levels in the ACC, by using the proton Magnetic Resonance Spectroscopy ([1H]MRS) system in adults with ADHD compared to healthy control subjects (HCS), before and after stimulant treatment, and to correlate between Glu and GABA levels and clinical symptoms.

Method:

ADHD adults ages 18-40 years (N= 35), and HCS (N= 25), will fill out a DSMV and ASRS questionnaire.

Spectroscopic analyses will be done using 1H MRS (3T) in ADHD adults, before and after stimulant treatment (Methylphenidate /Mixed Amphetamine salts) in an open-label fashion as compared to HCS. Proton spectra will be acquired from the ACC.

详细描述

Hypothesis:

  1. We hypothesize that brain Glu and GABA levels and/or their ratio involved in ADHD pathology
  2. Glu and GABA levels and/or their ratio will be affected by medical treatment in ADHD group
  3. Alteration of Glu and GABA and/or their ratios, before and after treatment, will correlate with clinical response to treatment

Primary Objectives:

To characterize changes in Glu and GABA levels in the ACC of adults with ADHD compared to the healthy subjects To characterize Glu and GABA levels in the ACC of adults with ADHD before and 1.5 hrs. after stimulant treatment using 1H MRS system.

Secondary objective:

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

盲法说明

No masking

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Giving informed written consent to participate on a voluntary basis.
  • For the healthy control group:
  • Men and women aged 18-40 years, who did not report ADHD or any other chronic or psychiatric illness or medical conditions (at most two symptoms of inattention and/or hyperactivity/impulsivity).
  • For the ADHD group patients:
  • Men and women aged 18-40 years, who have a diagnosis of ADHD, according to DSM V criteria by a Neurologist.
  • Have a valid prescription for Mixed Amphetamine salts (Attent) or short-acting methylphenidate (Ritalin) for ADHD
  • Withhold medication 72h prior to MRS scan.

排除标准

  • Exclusion criteria identical for patients and control group:
  • Subjects with metallic devices that precludemagnetic resonance imaging or any silver part that is not MRI compliant
  • Current presence of any other DSM V psychiatric disorder
  • Significant medical or neurological illness affecting brain function
  • Subjects with any clinically significant or unstable medical conditions
  • Use of any psychotropic medication, other than stimulants, in the previous 3 months
  • Pregnant women
  • History of brain MRI
  • A patient who does not agree that the scan will be decoded by a radiologist
  • A patient who does not agree that in case of an abnormal finding, the imaging results will be forwarded to the attending physician for further clarification
  • Understanding and/or language problems

结局指标

主要结局

Glu and GABA levels measured by MRS in ACC brain area

时间窗: 72 hours without stimulant

Differences in levels of Glu and GABA in ADHD patients compared to healthy volunteers

Glu and GABA levels measured by MRS in ACC brain area before and after medical treatment

时间窗: 90 minutes after stimulant

Differences in levels of Glu and GABA measured before and after medical treatment.

次要结局

  • Correlation of Glu and GABA levels with clinical symptoms before and after stimulants(210 minutes after stimulant)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验